Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease
Condition(s):Nontuberculous Mycobacterial Lung Disease; Mycobacterium Avium ComplexLast Updated:August 12, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Nontuberculous Mycobacterial Lung Disease; Mycobacterium Avium ComplexLast Updated:August 12, 2022Recruiting
Condition(s):Coronary StenosisLast Updated:December 6, 2022Recruiting
Condition(s):Surgical Blood Loss; Third MolarLast Updated:May 7, 2020Completed
Condition(s):Moderate to Severe AsthmaLast Updated:January 9, 2023Recruiting
Condition(s):Cystic FibrosisLast Updated:September 17, 2013Completed
Condition(s):Injection Site Irritation; Injection Site Bruising; Injection Site Discomfort; Benzoic Acid Adverse Reaction; Anesthesia, LocalLast Updated:November 5, 2021Not yet recruiting
Condition(s):Bronchiolitis, Viral; Saline Solution, HypertonicLast Updated:August 19, 2014Completed
Condition(s):SARS-CoV2 InfectionLast Updated:September 2, 2022Completed
Condition(s):Postural Tachycardia SyndromeLast Updated:August 23, 2022Active, not recruiting
Condition(s):Hemostasis After AdenoidectomyLast Updated:October 17, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.